Patents

US 11224592 B2: Aerosol pirfenidone and pyridone analog compounds and uses thereof

Granted
2022-01-18
Filed
2018-10-03 application 16151141
Type
Utility · 10 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Disclosed herein are formulations of pirfenidone or pyridone analog compounds for aerosolization and use of such formulations for aerosol administration of pirfenidone or pyridone analog compounds for the prevention or treatment of various fibrotic and inflammatory diseases, including disease associated with the lung, heart, kidney, liver, eye and central nervous system. In some embodiments, pirfenidone or pyridone analog compound formulations and delivery options described herein allow for efficacious local delivery of pirfenidone or pyridone analog compound. Compositions include all formulations, kits, and device combinations described herein. Methods include inhalation procedures, indications and manufacturing processes for production and use of the compositions described.

Source: PVGPATDIS, file of 2026-04-10 (ipg220118.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
AVALYN PHARMA INC. 13 patentsUS company or organizationSeattle, WAAvalyn Pharma Inc. State business registration EXACT high confidence: identical full name and state
Avalyn Pharma Inc. Form D issuer EXACT high confidence: identical full name and state
AVALYN PHARMA INC. SEC filer EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Mark William SurberSan Diego, CA31PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/4418PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P11/00PVGPATDIS, file of 2026-04-10
A61MDevices for introducing media into, or onto, the body ; devices for transducing body media or for taking media from the body ; devices for producing or ending sleep or stuporA61M15/009PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2019-03-19Name change
Change of name
GENOA PHARMACEUTICALS, INC. signed 2017-07-26AVALYN PHARMA INC. SEATTLE, WA48642/670PASDL, file of 2026-10-15
2019-03-19Assignment
Assignment of assignor's interest
SURBER, MARK WILLIAM signed 2012-04-12GENOA PHARMACEUTICALS, INC. SAN DIEGO, CA48641/556PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.